ANTI-Δ42PD1
ANTIBODY PLATFORM
![pipeline-photo](/cache/img/b482e18494bbb9282f259609fea03994.jpg)
PIPELINE
OUR
TEAM
![Dr. Percy Cheng](/cache/img/37578ac7239d43266b4ebbbadfa7b861.jpeg)
Dr. Percy CHENG
MH
(Co-Founder)
Executive Director
Chairman of the Board
![Jin Xia_photo window background_tuned final 2](/cache/img/dfdbddd155e4248d1211742ec7ceb764.jpg)
Dr. Xia JIN
(Co-Founder)
Executive Director
Chief Executive Officer
![Peter Tang](/cache/img/4829dff2788c18d0f47000dab0896cee.jpeg)
Mr. Peter TANG
(Co-Founder)
Director
![Chibo Tang_2_window](/cache/img/cb06c3ab9a0320e8122d0fbf9d85ed8b.png)
Mr. Chibo TANG
Director
![Dr. Leong](/cache/img/fe0ce6e530684e8a0140c456b7c88ba4.jpeg)
Dr. Che Hung LEONG, Edward
GBM, GBS, OBE, JP
Chairman of Advisory Board
![Dr. Ko](/cache/img/7fd532330276cb26f1508d9f08a4a801.jpeg)
Dr. Wing Man KO
GBS, JP
Advisory Board Member
![Dr. David Ho](/cache/img/b5a2b17e4395afb966ca4c765a02a340.jpeg)
Dr. Da I HO, David
Advisory Board Member
![Prof Chen](/cache/img/8e30f64ca4528b286bc557c23749ef13.jpeg)
Prof. Zhiwei CHEN
(Co-Founder)
Advisory Board Member
and Principal Scientific Advisor
![Mr. Tom Lau](/cache/img/258d4f2377161b2189ed0b4c46d814e7.jpeg)
Mr. Tom LAU
(Co-Founder)
Director of Corporate Finance
![Mark LO](/cache/img/6e5b684f4d9a4c432701a08caa15a44d.jpg)
Mr. Mark Lo
Chief Financial Officer
![Michael Wong](/cache/img/3a488360908b8c856767c7fe87c931b3.jpeg)
Dr. Michael WONG
Research and Development Director
![Pele Chong_window](/cache/img/3af965e08d0be38bbd4ea50c43039717.jpg)
Dr. Pele CHONG
Strategic Development Director
![Dr. Wai Sing Fai](/cache/img/db26680fcd994a4981cc8cdefa153601.jpeg)
Dr. Sing Fai WAI
Chief Technology Officer
![Wang Ting](/cache/img/466752e9dcca41a541c8c6c3bde9d193.jpeg)
Ms. Ting WANG
Clinical and Regulatory Director
![David Du](/cache/img/5cb0e9730c5786860beaef905b67a9ec.jpeg)
Mr. David Yanhua DU
General Manager of
Shenzhen Immuno Cure
![Andy Wong](/cache/img/401245b527fccbcc6ee4a270a995589a.jpeg)
Mr. Andy WONG
(Co-Founder)
Consultant
![shutterstock_607718810](/cache/img/d35e4d397bc9802e968037e19ebe49f7.jpg)
ABOUT
IMMUNO CURE
Immuno Cure is a biotechnology group based in the Hong Kong Science Park, focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA vaccine and Anti-Δ42PD1 Antibody Immune Blocking technology platforms; with 2 vaccines in first-in-human clinical trials.
Learn More